Literature DB >> 28991557

Screening for Breast Cancer.

Bethany L Niell1, Phoebe E Freer2, Robert Jared Weinfurtner3, Elizabeth Kagan Arleo4, Jennifer S Drukteinis3.   

Abstract

The goal of screening is to detect breast cancers when still curable to decrease breast cancer-specific mortality. Breast cancer screening in the United States is routinely performed with mammography, supplemental digital breast tomosynthesis, ultrasound, and/or MR imaging. This article aims to review the most commonly used breast imaging modalities for screening, discuss how often and when to begin screening with specific imaging modalities, and examine the pros and cons of screening. By the article's end, the reader will be better equipped to have informed discussions with patients and medical professionals regarding the benefits and disadvantages of breast cancer screening.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer detection rate; MR imaging; Mammography; Screening; Ultrasound

Mesh:

Year:  2017        PMID: 28991557     DOI: 10.1016/j.rcl.2017.06.004

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  31 in total

1.  Verification of the accuracy of a hybrid breast imaging simulation framework for virtual clinical trial applications.

Authors:  Liesbeth Vancoillie; Nicholas Marshall; Lesley Cockmartin; Janne Vignero; Guozhi Zhang; Hilde Bosmans
Journal:  J Med Imaging (Bellingham)       Date:  2020-04-22

2.  Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.

Authors:  Rosaria Meucci; Chiara Adriana Pistolese; Tommaso Perretta; Gianluca Vanni; Emanuela Beninati; Federica DI Tosto; Maria Lina Serio; Aurelia Caliandro; Marco Materazzo; Marco Pellicciaro; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 3.  Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.

Authors:  Gabriel B K Sasa; Cheng Xuan; Guoliang Lyu; Xianfeng Ding; Fang Meiyu
Journal:  Mol Biotechnol       Date:  2022-01-31       Impact factor: 2.695

4.  Value of BI-RADS 3 Audits.

Authors:  Prithwijit Roychowdhury; Gopal R Vijayaraghavan; John Roubil; Imani M Williams; Efaza Siddiqui; Srinivasan Vedantham
Journal:  Biomed J Sci Tech Res       Date:  2022-02-14

Review 5.  A literature review on the imaging methods for breast cancer.

Authors:  Reza Gerami; Saeid Sadeghi Joni; Negin Akhondi; Ali Etemadi; Mahnaz Fosouli; Aynaz Foroughi Eghbal; Zobin Souri
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-06-15

6.  Gastrointestinal metastatic signet ring cell breast cancer in young females: a case report.

Authors:  Liang Zhang; Lingyuan Wu; Jiyu Li; Shasha Song; Huanyu Lu; Chao Fang; Kunbing Zhu
Journal:  Gland Surg       Date:  2022-05

7.  Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.

Authors:  Li Jia; Guanhua Li; Na Ma; Aimin Zhang; Yunli Zhou; Li Ren; Dong Dong
Journal:  BMC Cancer       Date:  2022-07-12       Impact factor: 4.638

8.  An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry.

Authors:  Turkan Yigitbasi; Gizem Calibasi-Kocal; Nihal Buyukuslu; Murat Kemal Atahan; Hakan Kupeli; Seyran Yigit; Ercument Tarcan; Yasemin Baskin
Journal:  Biomed Rep       Date:  2018-01-15

9.  Breast cancer screening adherence rates and barriers of implementation in ethnic, cultural and religious minorities: A systematic review.

Authors:  Cristiana Sofia Ferreira; Joana Rodrigues; Stefanie Moreira; Filipa Ribeiro; Adhemar Longatto-Filho
Journal:  Mol Clin Oncol       Date:  2021-05-19

10.  Forewarned Is Forearmed: Can Better Patient Counseling Increase MRI Utilization in High-Risk Women?

Authors:  Amy E Cyr; Ranjna Sharma
Journal:  Ann Surg Oncol       Date:  2020-08-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.